Target intelligence / Profile preview

Ribosomal protein L5 pseudogene 18 (RPL5P18)

Target: RPL5P18
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L5 pseudogene 18 (RPL5P18) is a non-coding processed pseudogene related to the ribosomal protein L5 gene. It does not encode a functional protein product and is not considered a receptor, enzyme, transporter, or other therapeutic target. There is no evidence that RPL5P18 plays a direct role in any biological process or disease, and it is not implicated in drug interactions or therapeutic strategies. RPL5P18 is distinct from the actual RPL5 gene, which encodes a protein component of the ribosome with biological and disease relevance. The pseudogene (RPL5P18) should not be confused with the functional gene (RPL5). There are no reported functions, disease roles, or clinical utility associated with RPL5P18.

Other names: RPL5_11_750RPL5P18

Beyond the preview

Go deeper on Ribosomal protein L5 pseudogene 18 (RPL5P18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L5 pseudogene 18 (RPL5P18).

Explore the full profile